PeptideStack
5.2kquestions
20kanswers
220users

How many freeze-thaw cycles will ecnoglutide at 3.33 mg/mL tolerate?

Asked 12 Jan 2025Modified 15 months agoViewed 35k times
37

Conditions: ecnoglutide · 3.33 mg/mL.

I have done this once and I suspect I got away with it rather than got it right.

For context: I keep records of every batch, every lot number and every result, so an answer that requires me to track something is fine.

What does a defensible version of this look like in practice?

freeze-thaw
freeze-thaw

What repeated freezing does to a peptide in solution: ice-crystal shear at the growing front, freeze-concentration of solutes, pH shifts as buffer…

57 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
ecnoglutide
ecnoglutide

A long-acting GLP-1 receptor agonist with a cAMP-biased signalling profile. A niche tag, mostly used for mechanism questions about biased agonism…

223 questions
shareeditfollowflag
MS
askedmarta_szymanska10k1512 Jan 2025
3Same question here after a warm delivery, so I am following this. – Dr_Marek_Zielinski 9 months ago
4Worth saying whether the vial has been opened, because that starts a different clock. – kwn_analytical 11 days ago
add a comment

5 Answers

Accepted answer first, then by votes
20

Accepted answer

Nobody has published a cycle count, and at 3.33 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.33 mg and every microlitre is 3.33 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 3.33 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 3.33 mg/mL and the date, and never thaw a container you will refreeze.

Stated carefully, this is one of the few handling questions with a genuinely quantitative literature behind it.

Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.

The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.

Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.

Let a frozen vial reach room temperature before opening, or you condense water into it.

shareimprove this answerflag
CO
answered · acceptedcoldbox941k13813 Mar 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
23

Answering this needs to know whether the material is dry or in solution, since a dry powder is largely indifferent to a temperature cycle.

Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.

The part that matters: a dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

Dry powder tolerates cycles far better than solution does.

edited 14 Apr 2025 by orla_ferriter — added the method parameters

shareimprove this answerflag
OF
answeredorla_ferriter89k1485 Apr 2025
3I would add a sentence about light, since tryptophan-containing sequences care. – tess_amankwah 5 months ago
2Thank you — this is the answer I was looking for. – ravi_pillai 3 months ago
add a comment
14

Answer first: each freeze-thaw cycle costs something through aggregation and pH shift, so the mitigation is aliquoting rather than choosing a better freezer.

During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Count cycles, not degrees. The cycle is the damaging event.

shareimprove this answerflag
EV
answeredekaterina_volk21k2816 Apr 2025
Worth adding that residual moisture predicts this better than any printed date. – tobias_maartens 6 months ago
add a comment
7

Buffer components crystallise at different rates during freezing, which shifts pH locally by a surprising amount.

Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.

The number of tolerable cycles is sequence- and formulation-dependent and no general number is honest.

Thaw slowly and never refreeze an aliquot.

shareimprove this answerflag
DF
answeredDr_Colm_Fitzhenry69k24725 Mar 2025
6

Start with how many cycles are actually planned, because one or two are immaterial and ten are not.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

Cryoconcentration of solutes at the ice front is a well-documented mechanism in freeze-thaw damage to proteins and peptides.

Aliquot before the first freeze. That is the whole answer.

shareimprove this answerflag
TH
answeredtyndall_haze38k3819 Jan 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.